Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not sure why they bothered, with this telephone book thick prospectus, I received in the US mail.....What does it matter, even if I was to vote "No" reference the buy-out, at 19.75 ?
They have the vote, by more than 50%....So what's the reason to vote ?
Makes no sense.....It's done, sometime in March.......
Oh well, I guess I'm happy with the 19.75....Let it happen.
GMO.
Was hoping for more fan fair after the new year but can’t complain entered in $14 range.
CBMG.
There’s a big poker game going on here I believe. We have a Ceo trying to take a public company private. Is he releasing the best info on the company or keeping his cards close so the price didn’t go above 19.50?
While it’s just connecting dots, this process doesn’t feel right.
Guess it's time to say bye-bye, to Tony Liu and friends. At least they upped it a smidgin, to 19.75 per share. Don't know why they will delay the process greatly, with a shareholder vote for approval. Don't "they" own the majority of shares anyway ?
Crazy.....
Sounded like a promising bio-med company, headed to stardom, at a hundred plus per share eventually.....
JMO.
Cbmg did mention the possible partnership with China hospitals for stem cells to covid19 patients.
No. I’m not happy with 19.50. I’ve been with this group since Eastbridge.
I’m not so sure everything is a go with Allijon. Which may be the poker tell.
Still a ways off with the Car-t and Immunology for investors and trades. 5 years back when it popped it was bc of another Biotech was bought out traders thought cbmg may be next and Cbmg joined the Nasdaq.
I wonder if Cbmg could be the bridge for other Biotech JV’s in the U.S to get access to China? Sort of like the eastbridge model?
With the alljoin soon to be marketed and the deal with Novartis, within the next 5 years this should be a multi-hundred dollar stock.
I for one am not happy with a mere 19.50 buyout.
Btw, I used to be able to read a bunch of other people's opinions about CBMG and other tickers, on yahoo message board. But apparently they changed that. I think you have to be a paid member now, just to read stuff....
I guess he's entitled to do whatever he feels is right, for him and his pocket, or maybe him and his dreams of knee research. I'm pretty sure he's plenty comfortable in life, as far as personal wealth goes.
I'll bet if you asked him why he might go private, he'd probably say the whole process of maintaining a quality status on Nasdaq, with reporting every single penny involved, form 4 restrictions and scrutiny, people shorting the crap out of the stock, constant compliance and filings, etc, etc, etc.....
Maybe he's just tired of all the hassles of remaining listed.
That 40 dollar peak way back when, I think, was a momentary fluke. A payout at 19.50 a share, would satisfy most IMO.
Is it me or isn't there a conflict of interest that Tony (Bizuo) Liu is leading the effort to go private especially at this time in the company's development.
This company hit a price of over 40 dollars a share with just promises a few years back, today we have a contract with Novartis, phase 2 of rejoin and phase 3 of Aljoin and a bew facility in the US.
Yet only wants to offer 19.50 a share to us common shareholders.
Seems almost criminal to me.
Going private? Never have I seen such a thing. Always the opposite has been true, a private company going public, aka an IPO.....
Crazy.....
I guess the payout will be handsome at least, at 19.50 a share.
Sad. This was always one of my more profitable endeavours.....
Sorry to see it disappear.....
JMO.
What penny stock was it
For a company, that previously was a penny stock promoting cheesy IPOs, they have come a long way. Now they're shooting for a higher Nasdaq "presence", for probably a higher share price/value.....
If all of my long term pennystocks/microcaps could perform one tenth of this good, I would be tickled pink.....
JMO.
Since this board is inactive I will post another stock that may be similar to CBMG. Check out ETAH. Recent news came out and the stock jumped. I like the ETAH business model better than CBMG at this point and it is certainly cheaper. I do think however that CBMG will have a recurring revenue business model in the future. It wouldn't be bad to hold both stocks I suppose.
Big day for Cbmg to 18.00. I think it's the positive additions of 2 execs a few months ago along with the opening of a new facility.
And most important is the purchase of 29,000 shares by the CEO as looked at as a floor of risk for investors.
Investors as well look for new opportunities at the beginning of the yr.
The timing of news to come will be the deciding factor if we higher for more speculators to come in like they did 4 1/2 yrs ago with the thinking that cbmg may get bought out like others at the time.
That 45% down day was good advertising.
Coming back nicely, due to the new trial news. It still has to recover a 90% gain, just to make up for Friday's 45% loss....
Not fair, since it might have had a nice gain today, without last weeks decline....
Interesting articles....
I hate to "blame" the employees of the company.
However, their "given" shares seem to have come to maturity, in late April of this year. It's the only thing I see related, time-wise.
If so, I'm hoping other important staff members, don't do similar.....
Or maybe this. Coincident they both happen on the same day?
Ransomware virus plagues 100k computers across 99 countries
https://www.rt.com/news/388153-thousands-ransomeware-attacks-worldwide/
Huge Cyberattack Hits Nearly 100 Countries With ‘Wanna Decryptor’ Malware
http://www.nbcnews.com/news/world/national-health-service-cyberattack-hits-english-hospitals-hackers-demand-bitcoin-n758516
The only thing I could come up with were a few articles that discussed the stock price on a down hill slide and the stock technicals hitting extreme weakness. The only thing I could guess is this might have trigger a computer algorithm to start the sell out.
http://news.cmlviz.com/2017/05/07/breaking-down-cellular-biomedicine-group-inc-nasdaq-cbmg--stock-drop-below-support--technicals-hit-extreme-weakness.html
https://www.equities.com/news/cellular-biomedicine-group-inc-cbmg-settles-into-new-52-week-low-on-may-11-session
I could not find any thing negative about the company itself that would cause such a massive decline. There is no bad news out there on management, trials, stock multiplication, or write ups from any stock analysis.
Usually this type of extreme drop is triggered by some type of substantial event, and I'll be darn I can't find any anywhere.
The only thing I can speculate is that in late April, a ton of incentive shares from 2014 given to several officers, became "cashable". The only other guess is that if there is institutional ownership(ETFs/mutual funds/etc), the chief officer(s) lump selling triggered a bunch of bailing, due to stop limits.....
Kind of stupid, if the officers selling abruptly caused the days' decline.....They could have "trickled" their selling over several days/weeks, and the stock price probably wouldn't have dropped so hard.
Crazy speculation?
I don't see any other reasoning....
I can't find anything that might have caused this dcline today.
Anyone have a clue?
Jeez....45% down, in a day.....
I thought this thing had gone "legit".....
Rang the Nasdaq closing bell....
Only days ago, this thing was doing OK.
I guess I need to read the 10q, and any other relevant news.
Did Kwok take over?....
WTF ?
LOL
Me too. I still hold on to my ancient shares, simply because it's a success story like no other stock I've ever owned.
I'm a shareholder. Have been since they were an unknown OTC stock. So far I like their progress.
So. The Kwokster(director), buys a million dollars worth of shares, at 3.60 per share.....
Wow.....
Is anybody out there watching this thing? Or just me?
Ah yes....
The pre-planned selling, of about one third of all shares.
Lovely....
market may know something bad? It's year begin, why sell off.
$CBMG recent news/filings
bullish 24.59
long term bull flag continuation
## source: finance.yahoo.com
Fri, 13 Nov 2015 15:15:37 GMT ~ CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/151113/cbmg10-q.html
*********************************************************
Fri, 13 Nov 2015 14:21:16 GMT ~ Cellular Biomedicine Group Reports Third Quarter 2015 Financial Results and Provides Business Highlights
[GlobeNewswire] - SHANGHAI, China and CUPERTINO, Calif., Nov. 13, 2015-- Cellular Biomedicine Group Inc., a biomedicine firm engaged in the development of effective stem cell therapies for degenerative diseases and immunotherapies ...
read full: http://finance.yahoo.com/news/cellular-biomedicine-group-reports-third-142116365.html
*********************************************************
Wed, 11 Nov 2015 14:18:53 GMT ~ Cellular Biomedicine Group to Present HER-1-Targeted CAR-T Immunotherapy at CAR-T Summit 2015
[GlobeNewswire] - SHANGHAI, China and CUPERTINO, Calif., Nov. 11, 2015-- Cellular Biomedicine Group Inc., a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today ...
read full: http://finance.yahoo.com/news/cellular-biomedicine-group-present-her-141853262.html
*********************************************************
Mon, 09 Nov 2015 14:00:00 GMT ~ Cellular Biomedicine Group Opens New GMP Facility in Beijing
[GlobeNewswire] - SHANGHAI, China and CUPERTINO, Calif., Nov. 09, 2015-- Cellular Biomedicine Group Inc., a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today ...
read full: http://finance.yahoo.com/news/cellular-biomedicine-group-opens-gmp-140000717.html
*********************************************************
Tue, 03 Nov 2015 14:20:00 GMT ~ CBMG Responds to Inquiries From Investors and the Scientific Community About the Phase IIa Results From CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced B-cell Non-Hodgkin Lymphoma
[GlobeNewswire] - SHANGHAI, China and CUPERTINO, Calif., Nov. 03, 2015-- Cellular Biomedicine Group Inc., a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today ...
read full: http://finance.yahoo.com/news/cbmg-responds-inquiries-investors-scientific-142000894.html
*********************************************************
$CBMG charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CBMG company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CBMG/company-info
Ticker: $CBMG
OTC Market Place: Not Available
CIK code: 0001378624
Company name: Cellular Biomedicine Group, Inc.
Company website: http://www.cellbiomedgroup.com
Incorporated In: DE, USA
Business Description: Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, (i) haMPC (human adipose-derived mesenchymal progenitor cells) for treatment of joint disease, (ii) huMPC (human umbilical cord-derived mesenchymal progenitor cells), (iii) TC-DC (tumor cell specific dendritic cells) for treatment of a broad range of cancers and (iv) MNP (human embryo-derived motor neuron precursor cells) and NP (human embryo-derived neuronal precursor cells) for treatment of central nervous system diseases.Less >>
$CBMG share structure
## source: otcmarkets.com
Market Value: $285,727,562 a/o Nov 13, 2015
Shares Outstanding: 11,619,665 a/o Aug 03, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$CBMG extra dd links
Company name: Cellular Biomedicine Group, Inc.
Company website: http://www.cellbiomedgroup.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CBMG+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CBMG+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CBMG+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/news - http://finance.yahoo.com/q/h?s=CBMG+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CBMG/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CBMG+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CBMG
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cellular+Biomedicine+Group%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cellular+Biomedicine+Group%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cellular+Biomedicine+Group%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.cellbiomedgroup.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.cellbiomedgroup.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.cellbiomedgroup.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CBMG
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001378624&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CBMG&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CBMG
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CBMG+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CBMG+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CBMG
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CBMG
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CBMG+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CBMG/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CBMG+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CBMG.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CBMG
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CBMG
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CBMG
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CBMG:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CBMG
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CBMG
$CBMG DD Notes ~ http://www.ddnotesmaker.com/CBMG
$CBMG recent news/filings
bullish
## source: finance.yahoo.com
Tue, 30 Jun 2015 13:17:56 GMT ~ CBMG Today Responded to the Class Action Lawsuit
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new treatments for ...
read full: http://finance.yahoo.com/news/cbmg-today-responded-class-action-131756670.html
*********************************************************
Mon, 29 Jun 2015 13:00:00 GMT ~ Cellular Biomedicine Group Completes Acquisition of CD40LGVAX Vaccine
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new treatments for degenerative ...
read full: http://finance.yahoo.com/news/cellular-biomedicine-group-completes-acquisition-130000682.html
*********************************************************
Fri, 19 Jun 2015 19:30:00 GMT ~ MONDAY DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Cellular Biomedicine Group Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of June 22, 2015
[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:
read full: http://finance.yahoo.com/news/monday-deadline-levi-korsinsky-llp-193000800.html
*********************************************************
Thu, 18 Jun 2015 18:51:57 GMT ~ The Rosen Law Firm Reminds Cellular Biomedicine Group Inc. Investors of the Important June 22, 2015 Deadline in the Class Action -- CBMG
[GlobeNewswire] - NEW YORK -- The Rosen Law Firm, a global investor rights firm, reminds purchasers of Cellular Biomedicine Group Inc. securities from June 18, 2014 through April 7, 2015 of the important June 22, 2015 lead ...
read full: http://finance.yahoo.com/news/rosen-law-firm-reminds-cellular-185157430.html
*********************************************************
Tue, 16 Jun 2015 13:17:37 GMT ~ CBMG Selected for Inclusion in the Russell 3000 Index
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective treatments for degenerative ...
read full: http://finance.yahoo.com/news/cbmg-selected-inclusion-russell-3000-131737978.html
*********************************************************
$CBMG charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CBMG company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CBMG/company-info
Ticker: $CBMG
OTC Market Place: Not Available
CIK code: 0001378624
Company name: Cellular Biomedicine Group, Inc.
Company website: http://www.cellbiomedgroup.com
Incorporated In: DE, USA
Business Description: Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, (i) haMPC (human adipose-derived mesenchymal progenitor cells) for treatment of joint disease, (ii) huMPC (human umbilical cord-derived mesenchymal progenitor cells), (iii) TC-DC (tumor cell specific dendritic cells) for treatment of a broad range of cancers and (iv) MNP (human embryo-derived motor neuron precursor cells) and NP (human embryo-derived neuronal precursor cells) for treatment of central nervous system diseases.Less >>
$CBMG share structure
## source: otcmarkets.com
Market Value: $431,926,187 a/o Jul 01, 2015
Shares Outstanding: 11,514,961 a/o May 05, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$CBMG extra dd links
Company name: Cellular Biomedicine Group, Inc.
Company website: http://www.cellbiomedgroup.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CBMG+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CBMG+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CBMG+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/news - http://finance.yahoo.com/q/h?s=CBMG+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CBMG/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CBMG+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CBMG
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cellular+Biomedicine+Group%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cellular+Biomedicine+Group%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cellular+Biomedicine+Group%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.cellbiomedgroup.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.cellbiomedgroup.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.cellbiomedgroup.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CBMG
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001378624&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CBMG&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CBMG
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CBMG+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CBMG+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CBMG
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CBMG
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CBMG+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CBMG/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CBMG+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CBMG.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CBMG
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CBMG
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CBMG
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CBMG:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CBMG
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CBMG
$CBMG DD Notes ~ http://www.ddnotesmaker.com/CBMG
surfer - thanks. This in spite of all the lawsuits. I'm holding. Hope it follows in the footsteps of BLUE.
Why the rise especially in a down market?
Anyone know if we're exhibiting at ASCO in Chicago?
Keep tryin...Hagens/Berman...Lost cause....LOL
$CBMG recent news/filings
bullish
## source: finance.yahoo.com
Wed, 15 Apr 2015 10:04:05 GMT ~ CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and
read full: http://biz.yahoo.com/e/150415/cbmg8-k.html
*********************************************************
Tue, 14 Apr 2015 21:58:39 GMT ~ Nasdaq stocks posting largest percentage increases
[AP] - A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: Tonix Pharma rose 26.5 percent to $7.40. Trillium Therapeutic rose 16.4 percent to $11.12. Ebix Inc. rose 14.3 percent to ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************
Mon, 13 Apr 2015 10:10:27 GMT ~ CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-K/A, Annual Report
read full: http://biz.yahoo.com/e/150413/cbmg10-k_a.html
*********************************************************
Fri, 10 Apr 2015 17:25:00 GMT ~ 3 Stocks Breaking Out on Unusual Volume
read full: http://www.thestreet.com/story/13108534/1/3-stocks-breaking-out-on-unusual-volume.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Fri, 10 Apr 2015 13:30:00 GMT ~ Cellular Biomedicine Group to Present at ChinaBio(R) Partnering Forum in Shanghai on April 16, 2015
[GlobeNewswire] - SHANGHAI, China and PALO ALTO, Calif. -- Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective treatments for degenerative ...
read full: http://finance.yahoo.com/news/cellular-biomedicine-group-present-chinabio-133000937.html
*********************************************************
$CBMG charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CBMG company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CBMG/company-info
Ticker: $CBMG
OTC Market Place: Not Available
CIK code: 0001378624
Company name: Cellular Biomedicine Group, Inc.
Company website: http://www.cellbiomedgroup.com
Incorporated In: DE, USA
Business Description: Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, (i) haMPC (human adipose-derived mesenchymal progenitor cells) for treatment of joint disease, (ii) huMPC (human umbilical cord-derived mesenchymal progenitor cells), (iii) TC-DC (tumor cell specific dendritic cells) for treatment of a broad range of cancers and (iv) MNP (human embryo-derived motor neuron precursor cells) and NP (human embryo-derived neuronal precursor cells) for treatment of central nervous system diseases.Less >>
$CBMG share structure
## source: otcmarkets.com
Market Value: $339,752,762 a/o Apr 14, 2015
Shares Outstanding: 10,995,235 a/o Mar 18, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$CBMG extra dd links
Company name: Cellular Biomedicine Group, Inc.
Company website: http://www.cellbiomedgroup.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CBMG+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CBMG+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CBMG+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/news - http://finance.yahoo.com/q/h?s=CBMG+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CBMG/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CBMG+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CBMG
DTCC (dtcc.com): http://search2.dtcc.com/?q=Cellular+Biomedicine+Group%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Cellular+Biomedicine+Group%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Cellular+Biomedicine+Group%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.cellbiomedgroup.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.cellbiomedgroup.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.cellbiomedgroup.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CBMG
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001378624&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CBMG&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CBMG
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CBMG+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CBMG+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CBMG
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CBMG
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CBMG+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CBMG/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CBMG+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CBMG.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CBMG
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CBMG/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CBMG/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CBMG
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CBMG
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CBMG:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CBMG
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CBMG
$CBMG DD Notes ~ http://www.ddnotesmaker.com/CBMG
Something smelled fishy and somebody knew something bearish as early as Monday morning. Rallied to 38 plus then a 100k plus sell sold it off to 32. I knew then that bigger forces than I were at work. That's when I waited for a bounce and got lucky and sold everything at 36.05 for a small profit. Danger lurks in these markets folks............
What interesting this come out day they did a private placement for 38.00 per share.
Plus no mention of the product that is 1-2 years out for osteoarthritis of the knee.
Article claims CBMG evaluation was based on Car-t product which they purchased for 1.8 million, when in reality majority of the company's evaluation is based on the progress of the osteoarthritis product.
It is going to be interesting to see how company responds in am, and how bad the final fall out will be.
Unbelievable. Several other lawyer firms, have jumped on the "bandwagon".....Notice how all of them involve Jewish names...(No, I'm not predjudiced, just it's interesting how they're all like Green, Green, and Green....)
This could be big. With other biomed/pharmaceutical type stocks, when this type of "attack" happens, they either die a horrible death, or come out of it unscathed and innocent.....
From the beginning of my time in the pinks until today, this stock has stood out as the only sure-fire turd (in my mind) that did not meet its ultimate ugly fate. Not only that, but it has performed unbelievably well and, this is really hard to fathom, actually pulled off one of the siren songs of the pinks: moving to a more legitimate exchange. Mind boggling. Big Henry Fahman had his hands in this some time ago. Nothing he touches ever turns to gold it seems. Yet big CBMG (formerly EastBridge Investment Group) managed to make it. Or so it seemed. lol!
Well, lets hope most of these allegations are unfounded....
If they are untrue, then CBMG needs to sue the pants off of scott + scott.....
On the other hand if true, then bombs away...
(off shore stem cell research? sounds frankenstein-ish)
Yes it is, I bailed on the bounce @ 36.05. Will wait for the dust to clear.............Was up 3.00 plus too and instead was lucky with .75, bummer.
Heavily shorted today with record high volume today. It looks like CBMG is manipulated...
Another china Baidu in the making here? Waiting to see some fundamental follow thru.................
I didn't have any cash to add on the dip
Long now @ 35.30, may God help us all.......................
This one is now on my watch very closely list......................Shalom.
Yes, it's a buy-on-the-dip stock.
Followers
|
35
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
2750
|
Created
|
05/17/07
|
Type
|
Free
|
Moderators |
Cellular Biomedicine Group (NASDAQ: CBMG) is a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. We are the result of the acquisition, transfer, commercialization and advancement of thirty years of research and human treatment experience in cellular medicine. Our cellular research and development comes from collaboration among scientists and doctors from the US, Europe and China.
MARKET
Our primary target market is Greater China. Our first two therapy candidates are currently used to treat patients in research studies conducted in China. We are also engaged in a number of pre-clinical studies for other product or therapy candidates, which we believe have the potential to become safe and effective treatment options for a variety of degenerative and debilitating conditions. We believe that the results of our research studies will support expanded preclinical and clinical trials with a larger population of patients, which we expect to carry out through authorized treatment centers throughout Greater China. With the recent acquisition of AG, we added technical services revenue comprised of T Cells Receptor (“TCR”) clonality analysis technology and T Central Memory Cell (“Tcm”) and Dendritic Cell (“DC”) preparation methodologies.
Indication: Knee Osteoarthritis (KOA)
Technology Platform: Human Adipose-Derived Mesenchymal Progenitor Cells (haMPC)
Trial Phase: Clinical Trial Phase IIb, all patients completed treatment as of August 2014
Interim results from phase IIb clinical trial for KOA: klick here
Osteoarthritis is a degenerative disease of the joints. KOA is one of the most common types of osteoarthritis. Pathological manifestation of osteoarthritis is primarily local inflammation caused by immune response and subsequent damage of joints. Restoration of immune response and joint tissues are the objective of therapies.
According to International Journal of Rheumatic Diseases, 2011, 53% of KOA patients will degenerate to the point of disability. Conventional treatment usually involves invasive surgery with painful recovery and physical therapy. As drug-based methods of management are ineffective, the same journal estimates that some 1.5 million patients with this disability will degenerate to the point of requiring artificial joint replacement surgery every year. However, only 40,000 patients will actually be able to undergo replacement surgery, leaving the majority of patients to suffer from a life-long disability due to lack of effective treatment.
About haMPCs
haMPCs are currently being considered as a new and effective treatment for osteoarthritis, with a huge potential market. Osteoarthritis is one of the ten most disabling diseases in developed countries. Worldwide estimates are that 9.6% of men and 18.0% of women aged over 60 years have symptomatic osteoarthritis. It is estimated that the global OA therapeutics market was worth $4.4 billion in 2010 and is forecast to grow at a compound annual growth rate (“CAGR”) of 3.8% to reach $5.9 billion by 2018.
In order to bring haMPC-based KOA therapy to market, our market strategy is to: (a) establish regional laboratories that comply with cGMP standards in Shanghai and Beijing that meet Chinese regulatory approval; and (b) file joint applications with Class AAA hospitals (own commentary: press release from 09.02.2015 (klick here): We look forward to working with PLAGH as a long-term partner as we evaluate paths to commercialization,” commented Dr. William (Wei) Cao, Chief Executive Officer of Cellular Biomedicine Group.) to use haMPCs to treat KOA in a clinical trial setting.
Our KOA therapy is not surgically invasive – it uses a small amount (30ml) of adipose tissue obtained via liposuction from the patient, which is cultured and re-injected into the patient. The injections are designed to induce the body’s secretion of growth factors promoting immune response and regulation, and regrowth of cartilage. The down-regulation of the patient’s immune response is aimed at reducing and controlling inflammation which is a central cause of KOA.
We believe our proprietary method, subsequent haMPC proliferation and processing know-how will enable haMPC therapy to be a low cost and relatively safe and effective treatment for KOA. Additionally, banked haMPCs can continue to be stored for additional use in the future.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |